Symptom Severity and Guideline-Based Treatment Recommendations for Depressed Patients: Implications of DSM-5’s Potential Recommendation of the PHQ-9 as the Measure of Choice for Depression Severity
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The National Institute for Health and Clinical Excellence (NICE) and the recently revised American Psychiatric Association (APA) guidelines for the treatment of depression both indicate that the severity of depression should be considered when initiating treatment [1,2]. The NICE guidelines recommended psychotherapy as the first treatment option for mildly depressed patients. The APA treatment guidelines recommended either psychotherapy and pharmacotherapy as monotherapies for depression of mild or moderate severity, and pharmacotherapy (with or without psychotherapy) for severely depressed patients. If the severity of depression is to influence treatment choice in clinical practice, it is important to have available clinically useful, reliable and valid methods of distinguishing between levels of depression severity.Many scales have been developed to measure the severity of depression [3]. One of the most frequently used self-administered measures is the 9-item Patient Health Questionnaire (PHQ-9). In describing the initial development of the PHQ-9, Kroenke et al. [4] recommended cutoff scores corresponding to mild, moderate, moderately severe and severe levels of depression severity, and the validity of these cutoffs was supported by demonstrating differences in health-related quality of life between adjacent severity categories.In previewing the potential changes in the upcoming fifth edition of the Diagnostic and Statistical Manual, Regier et al. [5] noted that the most important advance of the DSM-5 will be the incorporation of dimensional ratings into the nosology. The DSM-5 Work Group for Depressive Disorders is considering the PHQ-9 as the preferred measure for quantifying the severity of depression. However, there are no studies empirically deriving the most valid cutoffs to demarcate severity gradations. Considering the importance accorded to symptom severity by the APA and NICE treatment guidelines in determining initial treatment efforts, the increasing use of the PHQ-9 in primary care settings, and the potential endorsement in DSM-5 that it be used to measure the severity of depression, it is important to examine the validity of the PHQ-9’s severity categorization.The PHQ-9 contains 9 items corresponding to the DSM-IV major depressive disorder criteria. The respondent is instructed to rate the symptom items on a 4-point Likert scale indicating how often they have been bothered by the symptom over the past 2 weeks (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day). Total scores on the scale range from 0 to 27. In their initial report on the validity of the PHQ-9, Kroenke et al. [4] indicated that the severity cutoff scores were chosen for the pragmatic reason of making them easier for clinicians to recall. They therefore used 5-point intervals to identify ranges of scores corresponding to severity levels (0–4 indicates no depression; 5–9, mild depression; 10–14, moderate depression; 15–19, moderately severe depression, and 20–27, severe depression). The authors also noted that alternative cutoffs did not increase the association between increasing PHQ-9 severity and indices of construct validity.To be sure, for all scales measuring the severity of depressive symptoms the thresholds distinguishing patients with mild, moderate and severe depression do not represent well-demarcated lines separating the severity subtypes. As with other areas of psychopathology, the severity of depression better corresponds to a dimensional than a categorical model of classification [6]. However, Kroenke et al. [4] did not consider how the broadness of severity ranges could impact on treatment selection when treatment selection, as described by official guideline recommendations, is guided by symptom severity. If severity distinctions might be used in the selection of treatment, then how broadly or narrowly these categories are defined will have significant clinical implications. It is therefore inappropriate to choose cutoffs to define the severity categories on the basis of their ease of recall.Kroenke et al. [4] presented the distribution of depressed patients falling into each of the grades of severity, and they found that more than one third of the primary care patients with major depressive disorder were severely depressed according to the PHQ-9, and only 10% were mildly depressed. We are skeptical that 3 times as many patients in primary care settings have severe depression than mild depression. We are also skeptical that more than one third of depressed primary care patients fall into the severe range. For the past 15 years we have integrated standardized rating scales into our clinical practice as part of the Methods to Improve Diagnostic Assessment and Services (MIDAS) project [7]. To date, we have evaluated more than 1,500 patients who met the DSM-IV criteria for major depressive disorder at the time of the evaluation. Patients were recruited into the MIDAS project withou
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Manea, L., Gilbody, S., & McMillan, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110829 · Cited by 1,966
Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care
Cameron, I. M., Crawford, J. R., Lawton, K., & Reid, I. C. (2008) · British Journal of General Practice · doi:10.3399/bjgp08x263794 · Cited by 590
The Conceptual Development of DSM-V
Regier, D. A., Narrow, W. E., Kuhl, E. A., & Kupfer, D. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020279 · Cited by 432
Comparison of two self-rating scales to detect depression: HADS and PHQ-9
Hansson, M., Chotai, J., Nordstöm, A., & Bodlund, O. (2009) · British Journal of General Practice · doi:10.3399/bjgp09x454070 · Cited by 246
Psychiatrists in the UK do not use outcomes measures: National survey
Gilbody, S. M., House, A. O., & Sheldon, T. A. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.2.101 · Cited by 234
Why Don't Psychiatrists Use Scales to Measure Outcome When Treating Depressed Patients?
Zimmerman, M., & McGlinchey, J. B. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1209 · Cited by 179
Self-citationCameron, I. M., Cardy, A., Crawford, J. R., du Toit, S. W., Hay, S., Lawton, K., Mitchell, K., Sharma, S., Shivaprasad, S., Winning, S., et al. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x583209 · Cited by 109
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00011 · Cited by 49
Self-citation
Cited by
Kocalevent, R.-D., Hinz, A., & Brähler, E. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.04.006 · Cited by 748
Muramatsu, K., Miyaoka, H., Kamijima, K., Muramatsu, Y., Tanaka, Y., Hosaka, M., Miwa, Y., Fuse, K., Yoshimine, F., Mashima, I., et al. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.03.007 · Cited by 345
Staging of Mental Disorders: Systematic Review
Cosci, F., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000342243 · Cited by 235
Kersting, A., Dölemeyer, R., Steinig, J., Walter, F., Kroker, K., Baust, K., & Wagner, B. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000348713 · Cited by 210
Wiersma, J. E., Van Schaik, D. J. F., Hoogendorn, A. W., Dekker, J. J., Van, H. L., Schoevers, R. A., Blom, M. B. J., Maas, K., Smit, J. H., McCullough Jr., J. P., et al. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000360795 · Cited by 79
Metadata
- Authors
- Zimmerman, M.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 81
- Issue
- 6
- Pages
- 329-332
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2057590786
- Cited by
- 41
- References
- 9
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Symptom Severity and Guideline-Based Treatment Recommendations for Depressed Patients: Implications of DSM-5’s Potential Recommendation of the PHQ-9 as the Measure of Choice for Depression Severity. https://app.cochat.ai/papers/10.1159/000342262
- The paper
- Zimmerman, M. (2012). Symptom Severity and Guideline-Based Treatment Recommendations for Depressed Patients: Implications of DSM-5’s Potential Recommendation of the PHQ-9 as the Measure of Choice for Depression Severity. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000342262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.